Renal Interstitial Fibrosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Renal Interstitial Fibrosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT01531257

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

Chronic Allograft Nephropathy (CAN)/Interstitial fibrosis and Tubular Atrophy (IFTA) is responsible for most kidney transplant failures. CAN/IFTA on a 3 month k…

United States1,000 participantsStarted 2010-04

All recent trials (28 shown)

CompletedNot Applicable

NCT06909968

Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Adv…

This is a prospective observational study done on 3 patient populations (cancer, chronic pulmonary and renal disease). All patients will be treated and monitore…

Italy178 participantsStarted 2020-12-14

Treatment: palliative care

By InvitationPhase 2

NCT06751602

Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

This is a randomized, double-blind, placebo-controlled trial in de novo kidney transplant patients to determine if the addition of belumosudil (brand name- REZU…

United States40 participantsStarted 2025-09-11

Treatment: Belumosudil 200 mg QD, Placebo

Renal Interstitial Fibrosis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

All recent trials (28 shown)

Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Adv…

Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

All recent trials (28 shown)

Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Adv…

Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)

The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

SELF-BREATHE RCT for Chronic Breathlessness

A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

Longitudinal Changes in Serum KL-6 in IPF

Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis

Magnetic Resonance Elastography of Transplanted Kidney (GREFFE_ELASTO IRM)

Special Drug Use Investigation of Ciproxan Injection in Pediatrics

Novartis Everolimus Transition

Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells

Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients

Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Al…

The Effects of Omega-3 Fatty Acids in Renal Transplantation

Furosemide Stress Test as a Predictor of Tubular Function in Chronic Kidney Disease

Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients